syros.com (SYRS) - Cash on Hand per Share

Corporate emblem and logo of Syros Pharmaceuticals, Inc (SYRS)

Syros Pharmaceuticals (SYRS) possesses strong scientific authority in genetic cancer control, although actual revenue is based on future sales of targeted drugs. The cash cushion per share trend on the GURU.Markets service reflects this balance, where 0.00 captures the magnitude of this parameter. However, the company's pricing power will remain hypothetical until clinical trials are completed and products enter the market.

syros.com (SYRS): Cash per Single Share from 07/04/2022 to 03/29/2025

Comprehensive metric breakdowns and analytics for Syros Pharmaceuticals Inc. (SYRS)

- stock value and consensus price forecast:
- cash position and cash flow details:
Summary company analysis:SYRS, Syros Pharmaceuticals, Inc
Manufactured product of Syros Pharmaceuticals, Inc.

For the Syros Pharmaceuticals (SYRS) biotech ecosystem, the current cash per share level reflects the financial stability of its targeted therapy development. This metric determines the portion of free liquidity attributable to a single security. The calculation is based on the ratio of total cash holdings to the number of outstanding shares. A high figure guarantees the autonomy of R&D processes and licensing agreements. However, excess capital may signal inefficient reinvestment into the platform's development.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share ImmunoPrecise Antibodies IPA|Cash per Single Share OMGA (omegatherapeutics.com)|Cash per Share Singular Genomics Systems, Inc. (OMIC)|Cash per Share RGLS (Regulus Therapeutics, Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology